drugset / Trial / NCT00882414
Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is to show the benefits for patients, with a high platelet count, iron deficiency and IBD, receiving intravenous iron therapy.
Timeline
- Start
- 2006-12
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferric carboxymaltose | Other / unclassified | 500 mg | Intravenous |
| Subject | Ferric carboxymaltose | Other / unclassified | 1000 mg | Intravenous |
| Subject | Ferric carboxymaltose | Other / unclassified | 1500 mg | Intravenous |